Page last updated: 2024-10-22

alendronate and Glioblastoma

alendronate has been researched along with Glioblastoma in 2 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jena, LN1
Bennie, LA1
McErlean, EM1
Pentlavalli, S1
Glass, K1
Burrows, JF1
Kett, VL1
Buckley, NE1
Coulter, JA1
Dunne, NJ1
McCarthy, HO1
Tricarico, PM1
Epate, A1
Celsi, F1
Crovella, S1

Other Studies

2 other studies available for alendronate and Glioblastoma

ArticleYear
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme.
    Journal of nanobiotechnology, 2021, May-04, Volume: 19, Issue:1

    Topics: Alendronate; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Surv

2021
Alendronate treatment induces IL-1B expression and apoptosis in glioblastoma cell line.
    Inflammopharmacology, 2018, Volume: 26, Issue:1

    Topics: Alendronate; Apoptosis; Brain; Cell Line, Tumor; Diphosphonates; Glioblastoma; Humans; Interleukin-1

2018